You have 9 free searches left this month | for more free features.

City

Cologne (1)

New York (1)

Condition

Esophageal Cancer (1)

Non-Small-Cell Lung Carcinoma (1)

Non-small Cell Lung Cancer (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Columbia University (1)

University of Cologne (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

fluoro-l-thymidine (2)

erlotinib, bevacizumab (1)

fluoro-d-glucose (1)

gadolinium-dpta (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

fluoro-l-thymidine

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Esophageal Cancer, NSCLC Trial in New York (Fluoro-L-Thymidine)

Terminated

Has Results

Esophageal Cancer
Non-small Cell Lung Cancer

Fluoro-L-Thymidine

New York, New York

Columbia University Medical Center

Aug 28, 2017

Non-Small-Cell Lung Carcinoma Trial in Cologne (Erlotinib, Bevacizumab, Fluoro-D-glucose, Fluoro-L-thymidine)

Completed

Non-Small-Cell Lung Carcinoma

Erlotinib, Bevacizumab
+3 more

Cologne, Northrhine-Westphalia, Germany

Center for Integrated Oncology (CIO), University Hospital Cologn

May 19, 2016